SkyePharma is a specialist drug delivery company developing oral and inhalation products. With a wide range of patented and proven technologies, SkyePharma aims to make good drugs better.
SkyePharma partners with a wide variety of companies from big Pharma, such as GlaxoSmithKline, Novartis, Sanofi-Aventis, AstraZeneca, Roche and Abbott Laboratories to a range of smaller speciality pharmaceutical companies. SkyePharma’s proprietary drug delivery technologies enable the development of new formulations of existing products as well as new chemical entities to provide a clinical benefit to patients.
16/05/12
Result of AGM16/05/12
Interim Management Statement11/05/12
Director/PDMR Shareholding27/04/12
Annual Information Update27/04/12
Holding(s) in Company23/04/12
Holding(s) in Company20/04/12
Exparel $10m milestone payment20/04/12
Flutiform Positive Outcome13/04/12
Annual Financial Report11/04/12
Respivert Contract
Copyright © Proactiveinvestors.co.uk, 2012. All Rights Reserved Design & Development: Tehnicom Computers
